Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding
Varices
Timing of Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding: Urgent vs. Elective Endoscopy
1 other identifier
interventional
60
1 country
1
Brief Summary
Liver cirrhosis is a common diffuse and persistent liver disease often accompanied by portal hypertension, liver failure, upper gastrointestinal bleeding (UGIB), and other complications. The incidence rate of liver cirrhosis with UGIB is as high as 30-40%, which is related to the rupture bleeding of gastroesophageal varices (GOV), hepatogenic ulcer, portal hypertensive gastropathy, hepatic gastrointestinal failure, etc
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 19, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedJanuary 19, 2024
January 1, 2024
1 year
January 8, 2024
January 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
in-hospital bleeding
Frequency of mortality in patients with variceal bleeding
One year
Study Arms (2)
Early band ligation
OTHERPatients with liver cirrhosis present with variceal bleeding underwent band ligation within 12 hours of presentation
Delayed band ligation
OTHERPatients with liver cirrhosis present with variceal bleeding underwent band ligation within more than 12 hours of presentation
Interventions
Eligibility Criteria
You may qualify if:
- Any patient who is above age of 18 years old and with liver cirrhosis and present with UGIB will be eligible for the study
You may not qualify if:
- Patients with age less than 18 years old
- Non-cirrhotic patients
- Patients with hemodynamic instability
- Patient's refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 71515, Egypt
Related Publications (1)
Kim J, Gong EJ, Seo M, Park JK, Lee SJ, Han KH, Kim YD, Jeong WJ, Cheon GJ, Seo HI. Timing of endoscopy in patients with upper gastrointestinal bleeding. Sci Rep. 2022 Apr 27;12(1):6833. doi: 10.1038/s41598-022-10897-3.
PMID: 35477727BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shaden Kelany, MSc
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Patient will be enrolled in one each group without masking
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 19, 2024
Study Start
February 1, 2024
Primary Completion
February 1, 2025
Study Completion
February 28, 2025
Last Updated
January 19, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share